Peripheral Blood Mononuclear Cell Biomarkers for Major Depressive Disorder: A Transcriptomic Approach
Depression and Anxiety · 2024-01 · 2024 (1)
DOI: 10.1155/2024/1089236 ↗Kurz gefasst
Fachartikel in der Zeitschrift Depression and Anxiety, online erschienen am 03.10.2024. Verfasst von Lu Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Mental Health Center of Jiangnan University, Wuxi Mental Health Center, Wuxi 214151, Jiangsu, China. Hauptthemen laut MEDLINE: Major Depressive Disorder, Leukocytes, Mononuclear, Transcriptome, TRPV Cation Channels. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Major depressive disorder (MDD) is a complex condition characterized by persistent depressed mood, loss of interest or pleasure, loss of energy or fatigue, and, in severe case, recurrent thoughts of death. Despite its prevalence, reliable diagnostic biomarkers for MDD remain elusive. Identifying peripheral biomarkers for MDD is crucial for early diagnosis, timely intervention, and ultimately reducing the risk of suicide. Metabolic changes in peripheral blood mononuclear cells (PBMCs) have been observed in animal models of depression, suggesting that PBMC could serve as a valuable matrix for exploring potential peripheral biomarkers in MDD.
Methods
We performed a transcriptomic analysis of PBMCs from patients with MDD and age‐ and sex‐matched healthy controls ( n = 20 per group).
Results
Our analysis identified 270 differentially expressed genes in PBMCs from MDD patients compared to controls, which correlated with the Hamilton Depression Rating Scale scores. These genes are involved in several KEGG pathways, including the herpes simplex virus 1 infection pathway, NOD‐like receptor signaling pathway, antigen processing and presentation, and glycerophospholipid metabolism—all of which are linked to various aspects of the immune response. Further machine learning analysis and quantitative real‐time PCR (qPCR) validation identified three key genes—TRPV2, ZNF713, and CTSL—that effectively distinguish MDD patients from healthy controls.
Conclusions
The immune dysregulation observed in PBMCs is closely related to the pathogenesis of MDD. The candidate biomarkers TRPV2, ZNF713, and CTSL, identified and validated through machine learning and qPCR, hold promise for the objective diagnosis of MDD. Trial Registration: Clinical Trial Registry identifier: ChiCTR2300076589
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Affiliated Mental Health Center of Jiangnan University, Wuxi Mental Health Center, Wuxi 214151, Jiangsu, China.
- Department of Rehabilitation Medicine, Wuxi Central Rehabilitation Hospital, Wuxi 214151, Jiangsu, China.
- Wuxi Maternity and Child Health Care Hospital, Wuxi School of Medicine, Jiangnan University, Wuxi 214002, China.
- Department of Fundamental Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, Jiangsu, China.
ORCID-Profile: Lu Sun, CaiLi Ren, HaoBo Leng, Xin Wang, DaoRan Wang, TianQi Wang, ZhiQiang Wang, GuoFu Zhang, Haitao Yu
Zitieren
APA
Sun, L., Ren, C., Leng, H., Wang, X., Wang, D., Wang, T., Wang, Z., Zhang, G., & Yu, H. (2024). Peripheral Blood Mononuclear Cell Biomarkers for Major Depressive Disorder: A Transcriptomic Approach. Depression and Anxiety, 2024(1). https://doi.org/10.1155/2024/1089236
Vancouver
Sun L, Ren C, Leng H, Wang X, Wang D, Wang T, et al. Peripheral Blood Mononuclear Cell Biomarkers for Major Depressive Disorder: A Transcriptomic Approach. Depression and Anxiety. 2024;2024(1). doi:10.1155/2024/1089236
BibTeX
@article{Sun2024,
author = {Sun, Lu and Ren, CaiLi and Leng, HaoBo and Wang, Xin and Wang, DaoRan and Wang, TianQi and Wang, ZhiQiang and Zhang, GuoFu and Yu, Haitao},
title = {Peripheral Blood Mononuclear Cell Biomarkers for Major Depressive Disorder: A Transcriptomic Approach},
journal = {Depression and Anxiety},
year = {2024},
volume = {2024},
number = {1},
doi = {10.1155/2024/1089236}
}
EUVIMED